Europe Topical Wound Agents Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Application (Chronic Wounds and Acute Wounds), By Product (Creams, Gels, Sprays, and Others), By Country and Growth Forecast, 2023 - 20

Europe Topical Wound Agents Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Application (Chronic Wounds and Acute Wounds), By Product (Creams, Gels, Sprays, and Others), By Country and Growth Forecast, 2023 - 2030


The Europe Topical Wound Agents Market would witness market growth of 8.0% CAGR during the forecast period (2023-2030).

The topical wound agents market has witnessed several notable developments to improve wound care, enhance healing outcomes, and address various challenges associated with acute and chronic wounds, such as advanced dressings, bioactive dressings, smart dressing, and negative pressure wound therapy. Advancements in the field of sophisticated dressings have been substantial. Dressings comprising novel substances, including hydrogels, foams, hydrocolloids, and alginates, have been developed by manufacturers. These dressings provide absorption, moisture regulation, and the establishment of an ideal healing environment. Antimicrobial agents are utilized in some to prevent infections.

Furthermore, bioactive dressings containing substances like silver, honey, or growth factors have gained attention for their ability to stimulate healing, control infection, and promote tissue regeneration. Technology integration into wound dressings has led to the creation of smart dressings embedded with sensors or indicators that monitor wound healing progress, detect infections, or measure pH and temperature changes, providing real-time data for healthcare providers. Advancements in negative pressure wound therapy systems have made topical wound agents more portable, user-friendly, and effective in managing complex wounds. These systems create a vacuum environment to promote healing by removing excess fluid, reducing edema, and promoting tissue granulation.

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), 25% of the working-age population has chronic illnesses. Annually, premature mortality among individuals of working age due to chronic diseases causes an economic detriment of €115 billion in the EU. Concerningly, 36% of EU individuals aged 65 and older were afflicted with at least two chronic diseases in 2020, and the prevalence of chronic diseases has increased at an accelerated rate over the past decade. In the EU, the prevalence of diabetes among adults has nearly doubled in the past twenty years, from approximately 17 million in 2000 to 33 million in 2019. The figure is expected to rise to 38 million by 2030. Therefore, the increasing rate of chronic disease in the region is increasing the demand in the market.

The Germany market dominated the Europe Topical Wound Agents Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $154.8 million by 2030. The UK market is showing a CAGR of 7.1% during (2023 - 2030). Additionally, The France market would register a CAGR of 8.9% during (2023 - 2030).

Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Application, the market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others), and Acute Wounds (Surgical & Traumatic, and Burns). Based on Product, the market is segmented into Creams, Gels, Sprays, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Viatris, Inc. (Mylan N.V.), AstraZeneca PLC, Coloplast Group, Novartis AG, Pfizer Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), and ConvaTec Group PLC

Scope of the Study

Market Segments covered in the Report:

By End-use
  • Hospitals
  • Clinics
  • Others
By Application
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others
  • Acute Wounds
  • Surgical & Traumatic
  • Burns
By Product
  • Creams
  • Gels
  • Sprays
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Smith & Nephew PLC
  • Teva Pharmaceutical Industries Ltd.
  • Molnlycke Health Care AB
  • Viatris, Inc. (Mylan N.V.)
  • AstraZeneca PLC
  • Coloplast Group
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • ConvaTec Group PLC
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Topical Wound Agents Market, by End-use
1.4.2 Europe Topical Wound Agents Market, by Application
1.4.3 Europe Topical Wound Agents Market, by Product
1.4.4 Europe Topical Wound Agents Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Topical Wound Agents Market by End-use
4.1 Europe Hospitals Market by Country
4.2 Europe Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Topical Wound Agents Market by Application
5.1 Europe Chronic Wounds Market by Country
5.2 Europe Topical Wound Agents Market by Chronic Wounds Type
5.2.1 Europe Diabetic Foot Ulcers Market by Country
5.2.2 Europe Pressure Ulcers Market by Country
5.2.3 Europe Venous Leg Ulcers Market by Country
5.2.4 Europe Others Market by Country
5.3 Europe Acute Wounds Market by Country
5.4 Europe Topical Wound Agents Market by Acute Wounds Type
5.4.1 Europe Surgical & Traumatic Market by Country
5.4.2 Europe Burns Market by Country
Chapter 6. Europe Topical Wound Agents Market by Product
6.1 Europe Creams Market by Country
6.2 Europe Gels Market by Country
6.3 Europe Sprays Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Topical Wound Agents Market by Country
7.1 Germany Topical Wound Agents Market
7.1.1 Germany Topical Wound Agents Market by End-use
7.1.2 Germany Topical Wound Agents Market by Application
7.1.2.1 Germany Topical Wound Agents Market by Chronic Wounds Type
7.1.2.2 Germany Topical Wound Agents Market by Acute Wounds Type
7.1.3 Germany Topical Wound Agents Market by Product
7.2 UK Topical Wound Agents Market
7.2.1 UK Topical Wound Agents Market by End-use
7.2.2 UK Topical Wound Agents Market by Application
7.2.2.1 UK Topical Wound Agents Market by Chronic Wounds Type
7.2.2.2 UK Topical Wound Agents Market by Acute Wounds Type
7.2.3 UK Topical Wound Agents Market by Product
7.3 France Topical Wound Agents Market
7.3.1 France Topical Wound Agents Market by End-use
7.3.2 France Topical Wound Agents Market by Application
7.3.2.1 France Topical Wound Agents Market by Chronic Wounds Type
7.3.2.2 France Topical Wound Agents Market by Acute Wounds Type
7.3.3 France Topical Wound Agents Market by Product
7.4 Russia Topical Wound Agents Market
7.4.1 Russia Topical Wound Agents Market by End-use
7.4.2 Russia Topical Wound Agents Market by Application
7.4.2.1 Russia Topical Wound Agents Market by Chronic Wounds Type
7.4.2.2 Russia Topical Wound Agents Market by Acute Wounds Type
7.4.3 Russia Topical Wound Agents Market by Product
7.5 Spain Topical Wound Agents Market
7.5.1 Spain Topical Wound Agents Market by End-use
7.5.2 Spain Topical Wound Agents Market by Application
7.5.2.1 Spain Topical Wound Agents Market by Chronic Wounds Type
7.5.2.2 Spain Topical Wound Agents Market by Acute Wounds Type
7.5.3 Spain Topical Wound Agents Market by Product
7.6 Italy Topical Wound Agents Market
7.6.1 Italy Topical Wound Agents Market by End-use
7.6.2 Italy Topical Wound Agents Market by Application
7.6.2.1 Italy Topical Wound Agents Market by Chronic Wounds Type
7.6.2.2 Italy Topical Wound Agents Market by Acute Wounds Type
7.6.3 Italy Topical Wound Agents Market by Product
7.7 Rest of Europe Topical Wound Agents Market
7.7.1 Rest of Europe Topical Wound Agents Market by End-use
7.7.2 Rest of Europe Topical Wound Agents Market by Application
7.7.2.1 Rest of Europe Topical Wound Agents Market by Chronic Wounds Type
7.7.2.2 Rest of Europe Topical Wound Agents Market by Acute Wounds Type
7.7.3 Rest of Europe Topical Wound Agents Market by Product
Chapter 8. Company Profiles
8.1 Smith & Nephew PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional and Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Teva Pharmaceutical Industries Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Molnlycke Health Care AB
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Viatris, Inc. (Mylan N.V.)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Coloplast Group
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Novartis AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Pfizer, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional & Segmental Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental &Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. ConvaTec Group PLC
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings